@article{3161878,
    title = "Meningococcal serogroup Y emergence in Europe High importance in some
European regions in 2012",
    author = "Broeker, Michael and Bukovski, Suzana and Culic, Davor and Jacobsson, and Susanne and Koliou, Maria and Kuusi, Markku and Simoes, Maria Joao and and Skoczynska, Anna and Toropainen, Maija and Taha, Muhamed-Keir and and Tzanakaki, Georgina",
    journal = "Human Vaccines & Immunotherapeutics",
    year = "2014",
    volume = "10",
    number = "6",
    pages = "1725-1728",
    publisher = "Landes Bioscience",
    issn = "2164-5515, 2164-554X",
    doi = "10.4161/hv.28206",
    keywords = "epidemiology; Europe; invasive meningococcal disease; serogroup Y;
meningococcal vaccines; surveillance",
    abstract = "Neisseria meningitidis is differentiated into 12 distinct serogroups, of
which A, B, C, W, X, and Y are medically most important and represent an
important health problem in different parts of the world. The
epidemiology of N. meningitidis is unpredictable over time and across
geographic regions. Recent epidemiological surveillance has indicated an
increase of serogroup Y invasive meningococcal disease in some parts of
Europe as shown in the epidemiological data for 2010 and 2011 from
various European countries previously published in this journal. 1,2
Here, data from 33 European countries is reported indicating that the
emergence of serogroup Y continued in 2012 in various regions of Europe,
especially in Scandinavia, while in Eastern and South-Eastern Europe the
importance of serogroup Y remained low."
}